Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...
Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
8h
GlobalData on MSNZealand Pharma steadfastly upholds amylin-based obesity drug strategyZealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results